Results 11 to 20 of about 44,752 (306)
Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition [PDF]
JAMA Internal Medicine, 2015 The expected duration of menopausal vasomotor symptoms (VMS) is important to women making decisions about possible treatments.To determine total duration of frequent VMS (≥ 6 days in the previous 2 weeks) (hereafter total VMS duration) during the menopausal transition, to quantify how long frequent VMS persist after the final menstrual period (FMP ...
Avis, Nancy E. +11 more
openaire +5 more sources
Women’s knowledge on the menopausal transition in relation to their socio-economic status
Menopause Review, 2021 Current reports indicate that there is a relationship between women’s socio-economic status (SES) and their level of knowledge on the menopausal transition.
Monika Krzyżanowska, Katarzyna Górecka
doaj +1 more source
Syndrome of perimenopausal melatonin deficiency is a new marker of women reproductive system aging
BIO Web of Conferences, 2020 The aim of our study was to determine a complex of risk factors of the perimenopausal melatonin deficiency syndrome (SPDM) in postmenopausal women and women during menopausal transition suffering from climacteric syndrome.
Mamontova Alexandra +2 more
doaj +1 more source
Factors influencing healthy menopause among immigrant women: a scoping review
BMC Women's Health, 2021 Background Many factors influence the menopausal transition and the complexity of this transition increases with the addition of immigration transition. This review aims to identify the factors that influence the menopausal transition for immigrant women
Ping Zou +6 more
doaj +1 more source
Neuroendocrine Changes during Menopausal Transition
Endocrines, 2021 Menopause is the permanent cessation of menstrual cycles following the loss of ovarian follicular activity. Quality of life of postmenopausal woman is the result of a series of psychobiological transformations, that see in the reduction of sex hormones ...
Andrea Giannini +3 more
doaj +1 more source
The impact of midlife on migraine in women: summary of current views
Women's Midlife Health, 2020 Migraine is three times more common in women than in men and is the 4th leading cause of disability in women. Onset of migraine increases at menarche, with peaks in prevalence in the late 30s, and a rapid decline after menopause.
Jelena M. Pavlović
doaj +1 more source
European Psychiatry, 2023 Background The menopause transition is a vulnerable period that can be associated with changes in mood and cognition. The present study aimed to investigate whether a symptomatic menopausal transition increases the risks of depression, anxiety, and sleep
Dong Yun Lee +13 more
doaj +1 more source
Purified and specific cytoplasmic pollen extract: a non-hormonal alternative for the treatment of menopausal symptoms. [PDF]
, 2020 Research into non-hormonal, alternative therapies is necessary for women for whom menopausal hormone therapy is contraindicated or for women who do not wish to take hormones.
Biglia, Nicoletta +14 more
core +4 more sources
Methods used in cross-culturalcomparisons of vasomotor symptoms and their determinants [PDF]
, 2011 Methodological differences among studies of vasomotor symptoms limit rigorous comparison or systematic review. Vasomotor symptoms generally include hot flushes and night sweats although other associated symptoms exist.
Anderson, Debra +3 more
core +2 more sources
Women's Midlife Health, 2021 Sexual self-efficacy is essential for appropriate and desirable sexual function and sexual quality of life. This study aimed to compare sexual quality of life and sexual self-efficacy among women during reproductive-menopausal transition stages and ...
Hedyeh Riazi +4 more
doaj +1 more source